
Thorium Norway AS Signs Five-Year radium-228 Sales Agreement with entX Limited
Thorium Norway AS has entered into a long-term off-take agreement with entX Limited (Australia) for the supply of radium-228. The agreement covers an initial five-year period, followed by a rolling 12-month mutual termination clause. Radium-228 will serve as a critical precursor for the production of medical isotopes used in advanced cancer treatments.
"We are proud to announce our first sales agreement and deeply appreciate the excellent collaboration with entX. Our team is fully committed to ensuring the successful delivery of radium-228," says Jan Børge Jakobsen, CEO of Thorium Norway AS.
About Thorium Norway AS Thorium Norway AS is dedicated to developing innovative industries to meet the growing global demand for thorium (Th-232). Backed by approximately 180 private investors, the company’s mission is to transform thorium-bearing mining residues from the Fen complex in Norway and other international sources into valuable products for the nuclear energy and pharmaceutical markets. Thorium Norway aims to lead a new industrial era in Norway and global supply, ensuring responsible management of low-radioactive materials and establishing a sustainable and future-oriented industry.
Visit www.thoriumnorway.com
About entX Limited entX advances innovation through nuclear science and engineering, with a strong focus on medical isotopes and healthcare applications. We develop scalable technologies that enable the production of critical precursors for life-saving diagnostic and therapeutic treatments, while supporting broader outcomes across energy, defence, and decarbonisation. Our solutions are designed to be sustainable, reliable, and globally impactful-helping transform healthcare delivery and improve patient outcomes worldwide.
Visit www.entx.com.au
Jan Børge Jakobsen
CEO
Thorium Norway AS
Email: jan.jakobsen@thoriumnorway.com
Phone: +47 95753904
Følg pressemeldinger fra Thorium Norway
Registrer deg med din e-postadresse under for å få de nyeste sakene fra Thorium Norway på e-post fortløpende. Du kan melde deg av når som helst.